122 related articles for article (PubMed ID: 28903383)
1. Association between ABO blood types and sporadic pancreatic neuroendocrine tumors in the Chinese Han population.
Ben Q; Liu J; Wang W; Guo F; Yao W; Zhong J; Yuan Y
Oncotarget; 2017 Aug; 8(33):54799-54808. PubMed ID: 28903383
[TBL] [Abstract][Full Text] [Related]
2. Risk Factors for Sporadic Pancreatic Neuroendocrine Tumors: A Case-Control Study.
Ben Q; Zhong J; Fei J; Chen H; Yv L; Tan J; Yuan Y
Sci Rep; 2016 Oct; 6():36073. PubMed ID: 27782199
[TBL] [Abstract][Full Text] [Related]
3. Pancreatic cancer incidence and outcome in relation to ABO blood groups among Han Chinese patients: a case-control study.
Ben Q; Wang K; Yuan Y; Li Z
Int J Cancer; 2011 Mar; 128(5):1179-86. PubMed ID: 20473916
[TBL] [Abstract][Full Text] [Related]
4. ABO blood group, hepatitis B viral infection and risk of pancreatic cancer.
Wang DS; Chen DL; Ren C; Wang ZQ; Qiu MZ; Luo HY; Zhang DS; Wang FH; Li YH; Xu RH
Int J Cancer; 2012 Jul; 131(2):461-8. PubMed ID: 21858814
[TBL] [Abstract][Full Text] [Related]
5. Diabetes, smoking, alcohol use, and family history of cancer as risk factors for pancreatic neuroendocrine tumors: a systematic review and meta-analysis.
Haugvik SP; Hedenström P; Korsæth E; Valente R; Hayes A; Siuka D; Maisonneuve P; Gladhaug IP; Lindkvist B; Capurso G
Neuroendocrinology; 2015; 101(2):133-42. PubMed ID: 25613442
[TBL] [Abstract][Full Text] [Related]
6. ABO blood group and nasopharyngeal carcinoma risk in a population of Southeast China.
Sheng L; Sun X; Zhang L; Su D
Int J Cancer; 2013 Aug; 133(4):893-7. PubMed ID: 23389798
[TBL] [Abstract][Full Text] [Related]
7. ABO Blood Group and Diabetes Mellitus Influence the Risk for Pancreatic Cancer in a Population from China.
Li X; Xu H; Gao P
Med Sci Monit; 2018 Dec; 24():9392-9398. PubMed ID: 30582832
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of risk factors for extrahepatic cholangiocarcinoma: ABO blood group, hepatitis B virus and their synergism.
Zhou Y; Zhou Q; Lin Q; Chen R; Gong Y; Liu Y; Yu M; Zeng B; Li K; Chen R; Li Z
Int J Cancer; 2013 Oct; 133(8):1867-75. PubMed ID: 23564396
[TBL] [Abstract][Full Text] [Related]
9. Surgery management for sporadic small (≤2 cm), non-functioning pancreatic neuroendocrine tumors: a consensus statement by the Chinese Study Group for Neuroendocrine Tumors (CSNET).
Yang G; Ji M; Chen J; Chen R; Chen Y; Fu D; Hou B; Huang H; Jiang L; Jin K; Ke N; Li Y; Li Y; Liang H; Liu A; Luo J; Ni Q; Shao C; Shen B; Sheng W; Song B; Sun J; Tan C; Tan H; Tang Q; Tang Y; Tian X; Wang J; Wang J; Wang W; Wang W; Wu Z; Xu J; Yan Q; Yang N; Yang Y; Yin X; Yu X; Yuan C; Zeng S; Zhang G; Zhang R; Zhou Z; Zhu Z; Shao C
Int J Oncol; 2017 Feb; 50(2):567-574. PubMed ID: 28035372
[TBL] [Abstract][Full Text] [Related]
10. ABO blood types and cancer risk--a cohort study of 339,432 subjects in Taiwan.
Sun W; Wen CP; Lin J; Wen C; Pu X; Huang M; Tsai MK; Tsao CK; Wu X; Chow WH
Cancer Epidemiol; 2015 Apr; 39(2):150-6. PubMed ID: 25600007
[TBL] [Abstract][Full Text] [Related]
11. Loss of DAXX and ATRX are associated with chromosome instability and reduced survival of patients with pancreatic neuroendocrine tumors.
Marinoni I; Kurrer AS; Vassella E; Dettmer M; Rudolph T; Banz V; Hunger F; Pasquinelli S; Speel EJ; Perren A
Gastroenterology; 2014 Feb; 146(2):453-60.e5. PubMed ID: 24148618
[TBL] [Abstract][Full Text] [Related]
12. Molecular alterations in sporadic pancreatic neuroendocrine microadenomas.
Hadano A; Hirabayashi K; Yamada M; Kawanishi A; Takanashi Y; Kawaguchi Y; Nakagohri T; Nakamura N; Mine T
Pancreatology; 2016; 16(3):411-5. PubMed ID: 26905832
[TBL] [Abstract][Full Text] [Related]
13. Long-Term Outcomes of Tuberous Sclerosis Complex-Associated Non-functional Pancreatic Neuroendocrine Tumors: Should We Be More Conservative?
Arya S; Ventin M; Nebbia M; Fernandez-Del Castillo C; Lionetto G; Qadan M; Lillemoe KD; Deshpande V; Catalano OA; Thiele EA; Ferrone CR
Ann Surg Oncol; 2023 Nov; 30(12):7748-7755. PubMed ID: 37648887
[TBL] [Abstract][Full Text] [Related]
14. The predictive value of mean platelet volume in differential diagnosis of non-functional pancreatic neuroendocrine tumors from pancreatic adenocarcinomas.
Karaman K; Bostanci EB; Aksoy E; Kurt M; Celep B; Ulas M; Dalgic T; Surmelioglu A; Hayran M; Akoglu M
Eur J Intern Med; 2011 Dec; 22(6):e95-8. PubMed ID: 22075321
[TBL] [Abstract][Full Text] [Related]
15. [Pancreatic cancer and ABO blood types: a study of cases and controls].
Vioque J; Walker AM
Med Clin (Barc); 1991 May; 96(20):761-4. PubMed ID: 1875761
[TBL] [Abstract][Full Text] [Related]
16. A comprehensive comparison of clinicopathologic and imaging features of incidental/symptomatic non-functioning pancreatic neuroendocrine tumors: A retrospective study of a single center.
Luo G; Liu Z; Guo M; Jin K; Xiao Z; Liu L; Liu C; Xu J; Ni Q; Long J; Yu X
Pancreatology; 2015; 15(5):519-524. PubMed ID: 26365059
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic Differentiation of Pancreatic Neuroendocrine Tumor From Other Neoplastic Solid Pancreatic Lesions During Endoscopic Ultrasound-Guided Fine-Needle Aspiration.
Krishna SG; Bhattacharya A; Li F; Ross WA; Ladha H; Porter K; Atiq M; Bhutani MS; Lee JH
Pancreas; 2016 Mar; 45(3):394-400. PubMed ID: 26418912
[TBL] [Abstract][Full Text] [Related]
18. The up-to-date review of epidemiological pancreatic neuroendocrine tumors in Japan.
Ito T; Lee L; Hijioka M; Kawabe K; Kato M; Nakamura K; Ueda K; Ohtsuka T; Igarashi H
J Hepatobiliary Pancreat Sci; 2015 Aug; 22(8):574-7. PubMed ID: 25689058
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for pancreatic neuroendocrine tumors: a clinic-based case-control study.
Halfdanarson TR; Bamlet WR; McWilliams RR; Hobday TJ; Burch PA; Rabe KG; Petersen GM
Pancreas; 2014 Nov; 43(8):1219-22. PubMed ID: 25291526
[TBL] [Abstract][Full Text] [Related]
20. Pancreatic Neuroendocrine Tumors: an Update.
Paniccia A; Edil BH; Schulick RD
Indian J Surg; 2015 Oct; 77(5):395-402. PubMed ID: 26722203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
